⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
EOLS News
Evolus, Inc. Common Stock
Form 8-K
sec.gov
EOLS
AEON Biopharma Abstract Accepted for Presentation at 2026 American Academy of Neurology (AAN) Annual Meeting
globenewswire.com
AEON
EOLS
AEON Biopharma Abstract Accepted for Presentation at 2026 American Academy of Neurology (AAN) Annual Meeting
globenewswire.com
AEON
EOLS
Form 8-K
sec.gov
EOLS
Evolus Reports Fourth Quarter and Full-Year 2025 Financial Results; Delivers Sixth Consecutive Year of Double-Digit Growth and Expects Sustainable Profitability 1 Beginning in 2026
businesswire.com
EOLS
Evolus to Participate in The Leerink Partners Global Healthcare Conference
businesswire.com
EOLS
Evolus to Report Fourth Quarter and Full-Year 2025 Financial Results on March 3, 2026
businesswire.com
EOLS
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
businesswire.com
EOLS
Evolus Announces Preliminary Unaudited Fourth Quarter and Full-Year 2025 Net Revenue
businesswire.com
EOLS
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
businesswire.com
EOLS